Browsing by Author "Ulaş, Turgay"

Now showing items 1-3 of 3

Hepatosplenomegaly and pernicious anaemia

Ulaş, Turgay; Yiǧit Karakaş, Emel; Bes, Cemal; Borlu, Fatih; Büyükhatipoǧlu, Hakan (Journal of Clinical and Diagnostic Research, 2014)

Sir,Pernicious anaemia (PA) is the end stage of atrophic gastritiswhich results in the loss of parietal cells in the fundus and bodyof the stomach. Loss of parietal cells is associated with the failureof intrinsic factor ...
Is chills an independent predictor factor for familial mediterranean fever severity score?

Bes, Cemal; Çağatay, Yonca; Ulaş, Turgay; Soy, Mehmet (BMJ Publishing Group, 2014)

...
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: A real-world data from Turkey

Dal, Mehmet Sinan; Ulu, Bahar Uncu; Uzay, Ant; Akay, Olga Meltem; Beşışık, Sevgi; Yenerel, Mustafa Nuri; Çelik, Serhat; Kaynar, Leylagül; Yücel, Orhan Kemal; Deveci, Burak; Sönmez, Mehmet; Mehtap, Özgür; Beköz, Hüseyin Saffet; Sunu, Cenk; Salim, Ozan; Ulaş, Turgay; Kartı, Sami; Altuntaş, Fevzi; Ferhanoğlu, Burhan; Tuğlular, Tülin Fırat (Springer, 2023)

Polatuzumab vedotin (Pola) with bendamustine and rituximab (BR) is a promising option for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). We analyzed the data of 71 R/R DLBCL patients who had ...